Bristol Myers Squibb (NYSE: BMY) strengthens Camzyos growth case with positive adolescent SCOUT-HCM data
Read More Pharma Industry News Dicerna, Roche strike $1.67bn deal for hepatitis B virus therapies Dicerna Pharmaceuticals has secured a research collaboration and licensing deal worth up to $1.67 billion with Roche to… bypharmanewsdailyNovember 2, 2019
